IFAN FINANCIAL, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.000001 USD | 0.00% |
|
0.00% | -99.75% |
| 2023 | IFAN Financial, Inc. announced that it expects to receive $0.124 million in funding | CI |
| 2019 | IFAN Financial, Inc. cancelled the transaction announced on April 21, 2016 | CI |
Financials (USD)
| Sales 2014 | - | Sales 2015 | - | Capitalization | 5.92M |
|---|---|---|---|---|---|
| Net income 2014 | - | Net income 2015 | -2M | EV / Sales 2014 | - |
| Net Debt 2014 | 146K | Net Debt 2015 | 620K | EV / Sales 2015 | - |
| P/E ratio 2014 |
-5.71
x | P/E ratio 2015 |
-2.43
x | Employees | 4 |
| Yield 2014 * |
-
| Yield 2015 |
-
| Free-Float | 100% |
More Fundamentals
* Assessed data
More news
1 month
0.00
0.00
Current year
0.000.00
1 year
0.000.00
3 years
0.000.05
5 years
0.000.05
10 years
0.001.01
| Managers | Title | Age | Since |
|---|---|---|---|
Larry Williams
CEO | Chief Executive Officer | - | 22-01-06 |
Steve Scholl
DFI | Director of Finance/CFO | 73 | 14-04-27 |
| President | 57 | 14-04-27 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| President | 57 | 14-04-27 | |
Steve Scholl
DFI | Director of Finance/CFO | 73 | 14-04-27 |
Larry Williams
CEO | Chief Executive Officer | - | 22-01-06 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-03 | 0.000001 | 0.00% | 130,000 |
Delayed Quote OTC Markets, May 03, 2024 at 01:30 pm EDT
More quotes
Palantir Bioceuticals, Inc., formerly IFAN Financial, Inc., is a biopharmaceutical company offering holistic solutions to mental health illnesses. The Company uses psychedelic-assisted psychotherapy (PAP), supervised use of ketamine, 3,4-Methylenedioxymethamphetamine (MDMA), psilocybin, Lysergic acid diethylamide (LSD), and ibogaine as part of elaborated psychotherapy programs.
Sector
Pharmaceuticals
| 1st Jan change | Capi. | |
|---|---|---|
| -99.75% | 1.21K | |
| +39.75% | 4.17B | |
| +148.03% | 2.33B | |
| +138.10% | 78.45M |
- Stock Market
- Equities
- IFAN Stock
